Yutrepia (treprostinil)

Manufacturer:
Liquidia
Site of Care:
Outpatient
Website: 
  • Manufacturer Website
Enrollment Forms:
Patient Support Form
VA Enrollment Form

Approved Indication:

  • pulmonary arterial hypertension (WHO group 1) to improve exercise ability
  • pulmonary hypertension associated with interstitial lung disease (PH-ILD, WHO group 3) to improve exercise ability

Conditions:

  • Pulmonary Arterial Hypertension (PAH)
  • Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)